ProstateProstate-Specific AntigenProstatic NeoplasmsProstatic HyperplasiaAndrogensReceptors, AndrogenProstatectomyAndrogen AntagonistsCell Line, TumorTransurethral Resection of ProstateOrchiectomyProstatic Intraepithelial NeoplasiaAdenocarcinomaNeoplasms, Hormone-DependentGene Expression Regulation, NeoplasticTreatment OutcomeProstatic DiseasesTumor Markers, BiologicalDihydrotestosteroneTime FactorsTosyl CompoundsDisease ProgressionDigital Rectal ExaminationFinasterideRetrospective StudiesBone NeoplasmsTumor Cells, CulturedMice, NudeCell ProliferationNeoplasm GradingBiopsy, NeedleImmunohistochemistryRisk FactorsAndrogen Receptor AntagonistsBrachytherapyProstatitisFollow-Up StudiesSensitivity and SpecificityApoptosisNeoplasm MetastasisBiopsyNeoplasm StagingCase-Control Studies5-alpha Reductase InhibitorsSeminal VesiclesProspective StudiesAnilidesCastrationWatchful WaitingTestosteroneSurgical Procedures, OperativeReproducibility of ResultsReverse Transcriptase Polymerase Chain ReactionRNA, MessengerFlutamideAntineoplastic Agents, HormonalMetribolonePrognosisSurgical Procedures, Minimally InvasiveAntineoplastic AgentsAzasteroidsGlutamate Carboxypeptidase IINeoplasm TransplantationNeoplasm InvasivenessTransplantation, HeterologousPostoperative ComplicationsSignal TransductionNeoplasm ProteinsXenograft Model Antitumor AssaysEpithelial Cells3-Oxo-5-alpha-Steroid 4-DehydrogenaseCohort StudiesRectumProstatic Neoplasms, Castration-ResistantRisk AssessmentCholestenone 5 alpha-ReductaseTestosterone CongenersBlotting, WesternCarcinomaUnited StatesGene Expression ProfilingPTEN PhosphohydrolaseGenetic Predisposition to DiseaseAndrogen-Binding ProteinIncidenceRadiotherapy, ConformalVascular Surgical ProceduresCell DivisionMass ScreeningMethodsProstatic Secretory ProteinsCell Growth ProcessesPredictive Value of TestsAnticarcinogenic AgentsNeoplasmsMice, SCIDMolecular Sequence DataRacemases and EpimerasesNeoplasm Recurrence, LocalBase Sequence